D
Pharma-Bio Serv, Inc.
PBSV
$0.55
$0.07515.79%
D
Sell
6/20/2024Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 6/20/2024 due to a significant decline in the valuation index, growth index and total return index. Operating cash flow declined 196.53% from $725.9 to -$700.7, and total revenue declined 0.11% from $2.38M to $2.38M.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 6/20/2024 due to a significant decline in the valuation index, growth index and total return index. Operating cash flow declined 196.53% from $725.9 to -$700.7, and total revenue declined 0.11% from $2.38M to $2.38M.
D
Sell
4/26/2024Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C- on 4/26/2024 due to a decline in the total return index and volatility index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C- on 4/26/2024 due to a decline in the total return index and volatility index.
C
Hold
4/11/2024Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C- from D+ on 4/11/2024 due to an increase in the volatility index and valuation index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C- from D+ on 4/11/2024 due to an increase in the volatility index and valuation index.
D
Sell
3/20/2024Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C- on 3/20/2024 due to a substantial decline in the valuation index, solvency index and efficiency index. Net income declined 474.73% from -$47.1 to -$270.7, the quick ratio declined from 8.78 to 4.97, and total capital declined 12.19% from $16.47M to $14.47M.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C- on 3/20/2024 due to a substantial decline in the valuation index, solvency index and efficiency index. Net income declined 474.73% from -$47.1 to -$270.7, the quick ratio declined from 8.78 to 4.97, and total capital declined 12.19% from $16.47M to $14.47M.
C
Hold
2/16/2024Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C- from D+ on 2/16/2024 due to an increase in the volatility index, valuation index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C- from D+ on 2/16/2024 due to an increase in the volatility index, valuation index and total return index.
D
Sell
2/1/2024Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C- on 2/1/2024 due to a decline in the volatility index and efficiency index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C- on 2/1/2024 due to a decline in the volatility index and efficiency index.
C
Hold
1/30/2024Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 1/30/2024 due to a significant decline in the growth index, efficiency index and volatility index. EBIT declined 111.25% from $460.5 to -$51.8, earnings per share declined from $0.0229 to -$0.0021, and net income declined 108.95% from $526.2 to -$47.1.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 1/30/2024 due to a significant decline in the growth index, efficiency index and volatility index. EBIT declined 111.25% from $460.5 to -$51.8, earnings per share declined from $0.0229 to -$0.0021, and net income declined 108.95% from $526.2 to -$47.1.
C
Hold
1/26/2024Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 1/26/2024 due to an increase in the volatility index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 1/26/2024 due to an increase in the volatility index and total return index.
C
Hold
1/9/2024Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 1/9/2024 due to a decline in the total return index, volatility index and valuation index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 1/9/2024 due to a decline in the total return index, volatility index and valuation index.
C
Hold
12/22/2023Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 12/22/2023 due to an increase in the total return index and volatility index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 12/22/2023 due to an increase in the total return index and volatility index.
C
Hold
11/28/2023Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 11/28/2023 due to a decline in the total return index and volatility index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 11/28/2023 due to a decline in the total return index and volatility index.
C
Hold
11/13/2023Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 11/13/2023 due to an increase in the valuation index, total return index and volatility index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 11/13/2023 due to an increase in the valuation index, total return index and volatility index.
C
Hold
10/17/2023Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 10/17/2023 due to a decline in the volatility index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 10/17/2023 due to a decline in the volatility index.
C
Hold
9/22/2023Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 9/22/2023 due to an increase in the valuation index, volatility index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 9/22/2023 due to an increase in the valuation index, volatility index and total return index.
C
Hold
9/14/2023Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 9/14/2023 due to a noticeable decline in the volatility index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 9/14/2023 due to a noticeable decline in the volatility index.
C
Hold
3/9/2023Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 3/9/2023 due to an increase in the volatility index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 3/9/2023 due to an increase in the volatility index and total return index.
C
Hold
2/22/2023Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 2/22/2023 due to a decline in the total return index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C- from C on 2/22/2023 due to a decline in the total return index.
C
Hold
2/7/2023Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 2/7/2023 due to an increase in the volatility index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 2/7/2023 due to an increase in the volatility index.
C
Hold
2/1/2023Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C- from D+ on 2/1/2023 due to a significant increase in the valuation index, growth index and volatility index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C- from D+ on 2/1/2023 due to a significant increase in the valuation index, growth index and volatility index.
D
Sell
10/17/2022Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 10/17/2022 due to an increase in the volatility index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 10/17/2022 due to an increase in the volatility index and total return index.
D
Sell
9/30/2022Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 9/30/2022 due to a decline in the volatility index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 9/30/2022 due to a decline in the volatility index and total return index.
D
Sell
9/15/2022Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 9/15/2022 due to an increase in the growth index, valuation index and volatility index. Operating cash flow increased 347.79% from -$446.3 to $1.11M, EBIT increased 31.68% from $280.6 to $369.5, and earnings per share increased from $0.01 to $0.0125.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 9/15/2022 due to an increase in the growth index, valuation index and volatility index. Operating cash flow increased 347.79% from -$446.3 to $1.11M, EBIT increased 31.68% from $280.6 to $369.5, and earnings per share increased from $0.01 to $0.0125.
D
Sell
8/4/2022Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 8/4/2022 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 8.79 to 8.51.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 8/4/2022 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 8.79 to 8.51.
D
Sell
5/31/2022Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 5/31/2022 due to an increase in the total return index and volatility index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 5/31/2022 due to an increase in the total return index and volatility index.
D
Sell
5/13/2022Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 5/13/2022 due to a decline in the volatility index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 5/13/2022 due to a decline in the volatility index.
D
Sell
4/18/2022Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 4/18/2022 due to an increase in the volatility index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 4/18/2022 due to an increase in the volatility index.
D
Sell
3/28/2022Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 3/28/2022 due to a noticeable decline in the volatility index, growth index and total return index. Operating cash flow declined 134.07% from $960.4 to -$327.2, and total revenue declined 10.33% from $5.6M to $5.02M.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 3/28/2022 due to a noticeable decline in the volatility index, growth index and total return index. Operating cash flow declined 134.07% from $960.4 to -$327.2, and total revenue declined 10.33% from $5.6M to $5.02M.
D
Sell
2/11/2022Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C on 2/11/2022 due to a significant decline in the valuation index, efficiency index and total return index. Net income declined 314.18% from $2.28M to -$4.87M, and total capital declined 20.4% from $24.54M to $19.53M.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C on 2/11/2022 due to a significant decline in the valuation index, efficiency index and total return index. Net income declined 314.18% from $2.28M to -$4.87M, and total capital declined 20.4% from $24.54M to $19.53M.
C
Hold
6/16/2021Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from C+ on 6/16/2021 due to a significant decline in the growth index, total return index and valuation index. Operating cash flow declined 301.53% from $588.2 to -$1.19M, EBIT declined 17.02% from $319.1 to $264.8, and earnings per share declined from $0.0116 to $0.01.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from C+ on 6/16/2021 due to a significant decline in the growth index, total return index and valuation index. Operating cash flow declined 301.53% from $588.2 to -$1.19M, EBIT declined 17.02% from $319.1 to $264.8, and earnings per share declined from $0.0116 to $0.01.
C
Hold
3/18/2021Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C+ from C on 3/18/2021 due to a large increase in the growth index, efficiency index and solvency index. EBIT increased 110.35% from $151.7 to $319.1, earnings per share increased from $0.006 to $0.0116, and net income increased 85.72% from $144.3 to $268.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C+ from C on 3/18/2021 due to a large increase in the growth index, efficiency index and solvency index. EBIT increased 110.35% from $151.7 to $319.1, earnings per share increased from $0.006 to $0.0116, and net income increased 85.72% from $144.3 to $268.
C
Hold
3/10/2021Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from B- on 3/10/2021 due to a noticeable decline in the total return index and volatility index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from B- on 3/10/2021 due to a noticeable decline in the total return index and volatility index.
B
Buy
2/23/2021Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to B- from C+ on 2/23/2021 due to a large increase in the total return index and volatility index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to B- from C+ on 2/23/2021 due to a large increase in the total return index and volatility index.
C
Hold
2/19/2021Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C+ from C on 2/19/2021 due to a significant increase in the growth index, total return index and volatility index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C+ from C on 2/19/2021 due to a significant increase in the growth index, total return index and volatility index.
C
Hold
9/15/2020Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from C+ on 9/15/2020 due to a significant decline in the growth index and valuation index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from C+ on 9/15/2020 due to a significant decline in the growth index and valuation index.
C
Hold
7/13/2020Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C+ from C on 7/13/2020 due to a substantial increase in the growth index, efficiency index and total return index. EBIT increased 34.2% from $536.8 to $720.4, earnings per share increased from $0.0229 to $0.0299, and net income increased 30.5% from $526.9 to $687.6.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C+ from C on 7/13/2020 due to a substantial increase in the growth index, efficiency index and total return index. EBIT increased 34.2% from $536.8 to $720.4, earnings per share increased from $0.0229 to $0.0299, and net income increased 30.5% from $526.9 to $687.6.
C
Hold
1/30/2020Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 1/30/2020 due to a large increase in the growth index, efficiency index and volatility index. EBIT increased 18.27% from $360.7 to $426.6, operating cash flow increased 13.95% from -$627.3 to -$539.8, and net income increased 10.76% from $431.2 to $477.6.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from C- on 1/30/2020 due to a large increase in the growth index, efficiency index and volatility index. EBIT increased 18.27% from $360.7 to $426.6, operating cash flow increased 13.95% from -$627.3 to -$539.8, and net income increased 10.76% from $431.2 to $477.6.
C
Hold
10/2/2019Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C- from D+ on 10/2/2019 due to an increase in the volatility index, growth index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C- from D+ on 10/2/2019 due to an increase in the volatility index, growth index and total return index.
D
Sell
9/17/2019Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C on 9/17/2019 due to a noticeable decline in the growth index, volatility index and total return index. Earnings per share declined from $0.0308 to $0.0187, EBIT declined 24.37% from $476.9 to $360.7, and total revenue declined 3.57% from $5.15M to $4.97M.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C on 9/17/2019 due to a noticeable decline in the growth index, volatility index and total return index. Earnings per share declined from $0.0308 to $0.0187, EBIT declined 24.37% from $476.9 to $360.7, and total revenue declined 3.57% from $5.15M to $4.97M.
C
Hold
1/30/2019Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from D+ on 1/30/2019 due to a significant increase in the valuation index, efficiency index and growth index. Net income increased 357.35% from $730.6 to $3.34M, earnings per share increased from $0.0317 to $0.1443, and EBIT increased 130.88% from $368.2 to $850.1.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C from D+ on 1/30/2019 due to a significant increase in the valuation index, efficiency index and growth index. Net income increased 357.35% from $730.6 to $3.34M, earnings per share increased from $0.0317 to $0.1443, and EBIT increased 130.88% from $368.2 to $850.1.
D
Sell
10/31/2018Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 10/31/2018 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 1,583.81% from -$151.3 to $2.25M, earnings per share increased from -$0.006 to $0.0317, and EBIT increased 346.78% from -$149.2 to $368.2.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 10/31/2018 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 1,583.81% from -$151.3 to $2.25M, earnings per share increased from -$0.006 to $0.0317, and EBIT increased 346.78% from -$149.2 to $368.2.
D
Sell
2/1/2017Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 2/1/2017 due to a significant decline in the valuation index, efficiency index and total return index. Net income declined 293.33% from -$130.5 to -$513.3, and total capital declined 2.27% from $22.37M to $21.86M.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 2/1/2017 due to a significant decline in the valuation index, efficiency index and total return index. Net income declined 293.33% from -$130.5 to -$513.3, and total capital declined 2.27% from $22.37M to $21.86M.
D
Sell
7/1/2016Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 7/1/2016 due to an increase in the total return index and volatility index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D+ from D on 7/1/2016 due to an increase in the total return index and volatility index.
D
Sell
6/30/2016Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D from D- on 6/30/2016 due to a significant increase in the efficiency index, solvency index and growth index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to D from D- on 6/30/2016 due to a significant increase in the efficiency index, solvency index and growth index.
D
Sell
6/15/2016Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D- from D on 6/15/2016 due to a significant decline in the efficiency index, solvency index and valuation index. The quick ratio declined from 14.65 to 12.64.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D- from D on 6/15/2016 due to a significant decline in the efficiency index, solvency index and valuation index. The quick ratio declined from 14.65 to 12.64.
D
Sell
3/17/2016Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 3/17/2016 due to a noticeable decline in the growth index, efficiency index and total return index. Operating cash flow declined 93.83% from $1.17M to $72.3, net income declined 33.14% from $523.5 to $350, and EBIT declined 32.09% from $565.6 to $384.1.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D from D+ on 3/17/2016 due to a noticeable decline in the growth index, efficiency index and total return index. Operating cash flow declined 93.83% from $1.17M to $72.3, net income declined 33.14% from $523.5 to $350, and EBIT declined 32.09% from $565.6 to $384.1.
D
Sell
3/11/2016Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C on 3/11/2016 due to a major decline in the volatility index, total return index and growth index. Total revenue declined 4.92% from $6.18M to $5.88M.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to D+ from C on 3/11/2016 due to a major decline in the volatility index, total return index and growth index. Total revenue declined 4.92% from $6.18M to $5.88M.
C
Hold
1/15/2016Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from C+ on 1/15/2016 due to a large decline in the total return index and valuation index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from C+ on 1/15/2016 due to a large decline in the total return index and valuation index.
C
Hold
12/31/2015Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C+ from C on 12/31/2015 due to an increase in the total return index, growth index and valuation index. Earnings per share increased from $0.015 to $0.019, EBIT increased 26.35% from $392 to $495.3, and total revenue increased 13.58% from $5.44M to $6.18M.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C+ from C on 12/31/2015 due to an increase in the total return index, growth index and valuation index. Earnings per share increased from $0.015 to $0.019, EBIT increased 26.35% from $392 to $495.3, and total revenue increased 13.58% from $5.44M to $6.18M.
C
Hold
7/1/2015Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from C+ on 7/1/2015 due to a decline in the volatility index, valuation index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from C+ on 7/1/2015 due to a decline in the volatility index, valuation index and total return index.
C
Hold
6/16/2015Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C+ from C on 6/16/2015 due to an increase in the growth index and valuation index. Earnings per share increased from $0.012 to $0.015, and EBIT increased 19.37% from $328.4 to $392.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to C+ from C on 6/16/2015 due to an increase in the growth index and valuation index. Earnings per share increased from $0.012 to $0.015, and EBIT increased 19.37% from $328.4 to $392.
C
Hold
6/15/2015Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from C+ on 6/15/2015 due to a decline in the volatility index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C from C+ on 6/15/2015 due to a decline in the volatility index and total return index.
C
Hold
6/1/2015Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C+ from B on 6/1/2015 due to a noticeable decline in the volatility index and valuation index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C+ from B on 6/1/2015 due to a noticeable decline in the volatility index and valuation index.
B
Buy
5/27/2015Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to B from C+ on 5/27/2015 due to a noticeable increase in the volatility index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to B from C+ on 5/27/2015 due to a noticeable increase in the volatility index.
C
Hold
5/26/2015Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C+ from B- on 5/26/2015 due to a decline in the volatility index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to C+ from B- on 5/26/2015 due to a decline in the volatility index and total return index.
B
Buy
5/11/2015Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B- from B on 5/11/2015 due to a decline in the volatility index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B- from B on 5/11/2015 due to a decline in the volatility index and total return index.
B
Buy
3/18/2015Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B from B+ on 3/18/2015 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 91.39% from $1.37M to $117.6, earnings per share declined from $0.035 to $0.012, and net income declined 65.12% from $826.9 to $288.4.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B from B+ on 3/18/2015 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 91.39% from $1.37M to $117.6, earnings per share declined from $0.035 to $0.012, and net income declined 65.12% from $826.9 to $288.4.
B
Buy
12/26/2014Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to B+ from B on 12/26/2014 due to an increase in the volatility index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to B+ from B on 12/26/2014 due to an increase in the volatility index.
B
Buy
12/11/2014Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B from B+ on 12/11/2014 due to a decline in the volatility index and valuation index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B from B+ on 12/11/2014 due to a decline in the volatility index and valuation index.
B
Buy
11/25/2014Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to B+ from B on 11/25/2014 due to a large increase in the volatility index and total return index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to B+ from B on 11/25/2014 due to a large increase in the volatility index and total return index.
B
Buy
10/30/2014Upgraded
Pharma-Bio Serv, Inc. (PBSV) was upgraded to B from B- on 10/30/2014 due to an increase in the volatility index and valuation index.
Pharma-Bio Serv, Inc. (PBSV) was upgraded to B from B- on 10/30/2014 due to an increase in the volatility index and valuation index.
B
Buy
10/15/2014Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B- from B on 10/15/2014 due to a noticeable decline in the volatility index, total return index and valuation index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B- from B on 10/15/2014 due to a noticeable decline in the volatility index, total return index and valuation index.
B
Buy
8/26/2014Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B from B+ on 8/26/2014 due to a large decline in the volatility index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B from B+ on 8/26/2014 due to a large decline in the volatility index.
B
Buy
7/11/2014Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B+ from A- on 7/11/2014 due to a major decline in the volatility index, growth index and total return index. Operating cash flow declined 150.36% from $1.75M to -$882.2, earnings per share declined from $0.028 to $0.014, and EBIT declined 49.34% from $827.6 to $419.3.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to B+ from A- on 7/11/2014 due to a major decline in the volatility index, growth index and total return index. Operating cash flow declined 150.36% from $1.75M to -$882.2, earnings per share declined from $0.028 to $0.014, and EBIT declined 49.34% from $827.6 to $419.3.
A
Buy
3/19/2014Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to A- from A on 3/19/2014 due to a major decline in the total return index, growth index and valuation index. Earnings per share declined from $0.052 to $0.028, EBIT declined 44.84% from $1.5M to $827.6, and operating cash flow declined 41.09% from $2.97M to $1.75M.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to A- from A on 3/19/2014 due to a major decline in the total return index, growth index and valuation index. Earnings per share declined from $0.052 to $0.028, EBIT declined 44.84% from $1.5M to $827.6, and operating cash flow declined 41.09% from $2.97M to $1.75M.
A
Buy
3/11/2014Downgrade
Pharma-Bio Serv, Inc. (PBSV) was downgraded to A from A+ on 3/11/2014 due to a noticeable decline in the total return index.
Pharma-Bio Serv, Inc. (PBSV) was downgraded to A from A+ on 3/11/2014 due to a noticeable decline in the total return index.
OTC PK
03/10/2025 9:54AM Eastern
Quotes delayed
